Home
RNXT
RNXT News

Latest RenovoRx Inc. (RNXT) News on November 15, 2024

RenovoRx Reports Third Quarter 2024 Financial Results and Operational Highlights

GlobeNewswire

16 hours ago

RenovoRx Reports Third Quarter 2024 Financial Results and Operational Highlights

We Think RenovoRx (NASDAQ:RNXT) Needs To Drive Business Growth Carefully

Simply Wall St.

2 months ago

We Think RenovoRx (NASDAQ:RNXT) Needs To Drive Business Growth Carefully

RenovoRx Increases Production of FDA-Cleared RenovoCath® Delivery System in Response to Strong Demand from Oncology and Interventional Radiology Physicians

GlobeNewswire

2 months ago

RenovoRx Increases Production of FDA-Cleared RenovoCath® Delivery System in Response to Strong Demand from Oncology and Interventional Radiology Physicians

RenovoRx Announces Presentation at Symposium on Clinical Interventional Oncology Highlighting TAMP™ for Targeted Treatment of Locally Advanced Pancreatic Cancer

GlobeNewswire

2 months ago

RenovoRx Announces Presentation at Symposium on Clinical Interventional Oncology Highlighting TAMP™ for Targeted Treatment of Locally Advanced Pancreatic Cancer

RenovoRx CEO Shaun Bagai to Present at H.C. Wainwright’s 26th Annual Global Investment Conference on September 9, 2024 in New York

GlobeNewswire

3 months ago

RenovoRx CEO Shaun Bagai to Present at H.C. Wainwright’s 26th Annual Global Investment Conference on September 9, 2024 in New York

RenovoRx continues drug-device combo Phase III trial in pancreatic cancer

Medical Device Network

3 months ago

RenovoRx continues drug-device combo Phase III trial in pancreatic cancer

RenovoRx Announces First Patient Enrolled at University of Nebraska Medical Center for the Ongoing Pivotal Phase III TIGeR-PaC Clinical Trial

GlobeNewswire

3 months ago

RenovoRx Announces First Patient Enrolled at University of Nebraska Medical Center for the Ongoing Pivotal Phase III TIGeR-PaC Clinical Trial

RenovoRx Announces Publication of Positive Early-Stage Clinical Data in International Peer-Reviewed Journal, The Oncologist®

GlobeNewswire

3 months ago

RenovoRx Announces Publication of Positive Early-Stage Clinical Data in International Peer-Reviewed Journal, The Oncologist®

RenovoRx Announces Acceptance for Publication in the International Peer-Reviewed Journal, The Oncologist®

GlobeNewswire

4 months ago

RenovoRx Announces Acceptance for Publication in the International Peer-Reviewed Journal, The Oncologist®

University of Nebraska Medical Center Launches Patient Enrollment for RenovoRx’s Pivotal Phase III TIGeR-PaC Clinical Trial

GlobeNewswire

5 months ago

University of Nebraska Medical Center Launches Patient Enrollment for RenovoRx’s Pivotal Phase III TIGeR-PaC Clinical Trial

RenovoRx Appoints Ryan Witt as Senior Vice President, Head of Corporate Strategy and Partnerships

GlobeNewswire

5 months ago

RenovoRx Appoints Ryan Witt as Senior Vice President, Head of Corporate Strategy and Partnerships

RenovoRx CEO Issues Update Letter to Shareholders

Business Wire

6 months ago

RenovoRx CEO Issues Update Letter to Shareholders

Publication of Results of Pre-Clinical Studies Support Efficacy and Drug Delivery Mechanism Potential of RenovoRx’s TAMP™ Therapy Platform to Improve Targeted Cancer Drug Treatment Delivery

Business Wire

6 months ago

Publication of Results of Pre-Clinical Studies Support Efficacy and Drug Delivery Mechanism Potential of RenovoRx’s TAMP™ Therapy Platform to Improve Targeted Cancer Drug Treatment Delivery

RenovoRx to Participate in Fireside Chat at the A.G.P. Virtual Healthcare Company Showcase on May 21, 2024

Business Wire

6 months ago

RenovoRx to Participate in Fireside Chat at the A.G.P. Virtual Healthcare Company Showcase on May 21, 2024

Business Wire

6 months ago

RenovoRx CEO Shaun R. Bagai to Present at the Aegis Capital Virtual Conference on May 9, 2024

RenovoRx Regains Compliance with Nasdaq Stockholders’ Equity Requirement

Business Wire

7 months ago

RenovoRx Regains Compliance with Nasdaq Stockholders’ Equity Requirement

RenovoRx Highlights Recent Presentation of Clinical Data Abstract at the 2024 Society of Interventional Radiology Annual Scientific Meeting

Business Wire

7 months ago

RenovoRx Highlights Recent Presentation of Clinical Data Abstract at the 2024 Society of Interventional Radiology Annual Scientific Meeting

RenovoRx Closes $11.1 Million Private Placement, Providing Cash Runway into 2026

Business Wire

7 months ago

RenovoRx Closes $11.1 Million Private Placement, Providing Cash Runway into 2026

RenovoRx Announces $11.1 Million at Market Private Placement

Business Wire

7 months ago

RenovoRx Announces $11.1 Million at Market Private Placement

RenovoRx to Present at the Canaccord Genuity Horizons in Oncology Virtual Conference on April 15, 2024

Business Wire

7 months ago

RenovoRx to Present at the Canaccord Genuity Horizons in Oncology Virtual Conference on April 15, 2024

RenovoRx to Present at the 36th Annual ROTH Conference on March 19, 2024

Business Wire

8 months ago

RenovoRx to Present at the 36th Annual ROTH Conference on March 19, 2024

RenovoRx Highlights Key Leadership Promotions

Business Wire

8 months ago

RenovoRx Highlights Key Leadership Promotions

RenovoRx CEO Issues Letter to Shareholders

Business Wire

9 months ago

RenovoRx CEO Issues Letter to Shareholders

RenovoRx Closes $6.1 Million Private Placement

Business Wire

10 months ago

RenovoRx Closes $6.1 Million Private Placement

Femasys Inc. Begins FemBloc Pivotal Trial Enrollment at UC Davis Medical Center, a Hub for Innovation and Groundbreaking Research in Health Care for Women

GlobeNewswire

10 months ago

Femasys Inc. Begins FemBloc Pivotal Trial Enrollment at UC Davis Medical Center, a Hub for Innovation and Groundbreaking Research in Health Care for Women

Forbes-Approved: CareCloud is Streamlining Healthcare with Smart Technology for All Practices

GlobeNewswire

10 months ago

Forbes-Approved: CareCloud is Streamlining Healthcare with Smart Technology for All Practices

Business Wire

10 months ago

Permianville Royalty Trust Announces Monthly Operational Update

WYNNEFIELD CAPITAL IMPLORES TECHPRECISION TO GIVE ALL SHAREHOLDERS A VOICE IN VOTAW PRECISION TECHNOLOGIES TRANSACTION

PR Newswire

10 months ago

WYNNEFIELD CAPITAL IMPLORES TECHPRECISION TO GIVE ALL SHAREHOLDERS A VOICE IN VOTAW PRECISION TECHNOLOGIES TRANSACTION

5E Advanced Materials Selects EPC Contractor Fluor Corporation For Process Engineering Work on FEL-2

GlobeNewswire

10 months ago

5E Advanced Materials Selects EPC Contractor Fluor Corporation For Process Engineering Work on FEL-2

TuSimple Announces Intention to Delist from Nasdaq

PR Newswire

10 months ago

TuSimple Announces Intention to Delist from Nasdaq

Personalis Announces Medicare Coverage for NeXT Dx(R) Comprehensive Genomic Tumor Profiling Assay

Business Wire

10 months ago

Personalis Announces Medicare Coverage for NeXT Dx(R) Comprehensive Genomic Tumor Profiling Assay

Business Wire

10 months ago

TSR, Inc. Reports Results for the Second Quarter Ended November 30, 2023

Creative Realities to Debut as Exhibitors at NRF 2024: Retail’s Big Show

GlobeNewswire

10 months ago

Creative Realities to Debut as Exhibitors at NRF 2024: Retail’s Big Show

Fortune Rise Acquisition Corporation Receives January Monthly Extension From Sponsor Affiliate to Complete its Initial Business Combination

ACCESSWIRE

10 months ago

Fortune Rise Acquisition Corporation Receives January Monthly Extension From Sponsor Affiliate to Complete its Initial Business Combination

Cardio Diagnostics Holdings, Inc. Announces the Grant of a Patent in India

Business Wire

10 months ago

Cardio Diagnostics Holdings, Inc. Announces the Grant of a Patent in India

Edgio Promotes Todd Hinders to Chief Executive Officer

Business Wire

10 months ago

Edgio Promotes Todd Hinders to Chief Executive Officer

Akari Therapeutics Announces Existing Investors Support the Company Through a $2 Million Private Placement Financing

GlobeNewswire

10 months ago

Akari Therapeutics Announces Existing Investors Support the Company Through a $2 Million Private Placement Financing

GigCapital5, Inc. Announces Stockholder Approval of Extension Amendment to the Amended and Restated Certificate of Incorporation and Investment Management Trust Agreement

Business Wire

a year ago

GigCapital5, Inc. Announces Stockholder Approval of Extension Amendment to the Amended and Restated Certificate of Incorporation and Investment Management Trust Agreement

Surf Air Mobility Enters into Binding Terms for a $35.2 Million Mandatory Convertible Debenture with GEM Global Yield LLC

Business Wire

a year ago

Surf Air Mobility Enters into Binding Terms for a $35.2 Million Mandatory Convertible Debenture with GEM Global Yield LLC

Karuna downgraded, Arm target raised: Wall Street's top analyst calls

The Fly

a year ago

Karuna downgraded, Arm target raised: Wall Street's top analyst calls

RenovoRx Engages Oklahoma University (OU) Health as First Clinical Site in Preparation for the Pivotal Phase III CouGar Clinical Trial in Bile Duct Cancer

Business Wire

a year ago

RenovoRx Engages Oklahoma University (OU) Health as First Clinical Site in Preparation for the Pivotal Phase III CouGar Clinical Trial in Bile Duct Cancer

RenovoRx Announces Clinical Data Abstract at the 2024 Society of Interventional Radiology Annual Scientific Meeting

Business Wire

a year ago

RenovoRx Announces Clinical Data Abstract at the 2024 Society of Interventional Radiology Annual Scientific Meeting

Outlook Therapeutics® Submits Special Protocol Assessment (SPA) to FDA for Non-Inferiority Study of ONS-5010

GlobeNewswire

a year ago

Outlook Therapeutics® Submits Special Protocol Assessment (SPA) to FDA for Non-Inferiority Study of ONS-5010

IZEA Founder Ted Murphy Named on Comparably’s ‘Best CEO’ List for Third Consecutive Year

GlobeNewswire

a year ago

IZEA Founder Ted Murphy Named on Comparably’s ‘Best CEO’ List for Third Consecutive Year

RenovoRx Files New International Patent for Novel Targeted Combination Drug-Delivery Oncology Therapy Platform

Business Wire

a year ago

RenovoRx Files New International Patent for Novel Targeted Combination Drug-Delivery Oncology Therapy Platform

Aadi Bioscience, Inc. (NASDAQ:AADI) is definitely on the radar of institutional investors who own 39% of the company

Simply Wall St.

a year ago

Aadi Bioscience, Inc. (NASDAQ:AADI) is definitely on the radar of institutional investors who own 39% of the company

SPI Announces Adjournment of Annual Meeting of Shareholders Due to Lack of Quorum

ACCESSWIRE

a year ago

SPI Announces Adjournment of Annual Meeting of Shareholders Due to Lack of Quorum

Curis Presented Clinical Data from the TakeAim Leukemia Study at the 2023 ASH Conference

PR Newswire

a year ago

Curis Presented Clinical Data from the TakeAim Leukemia Study at the 2023 ASH Conference

Lion Electric Announces Successful Final Certification of its LionBattery MD Battery Pack

CNW Group

a year ago

Lion Electric Announces Successful Final Certification of its LionBattery MD Battery Pack

20 Most Popular Nuts in the World

Insider Monkey

a year ago

20 Most Popular Nuts in the World

VCI Global Limited and Evolve Capital Forge Collaboration to Enhance Market Access and Listing Opportunities Across International Exchanges

GlobeNewswire

a year ago

VCI Global Limited and Evolve Capital Forge Collaboration to Enhance Market Access and Listing Opportunities Across International Exchanges

Greenland Technologies to Present at Water Tower Research’s Hybrid US Climate Investor Conference on December 7

GlobeNewswire

a year ago

Greenland Technologies to Present at Water Tower Research’s Hybrid US Climate Investor Conference on December 7

RYVYL Announces Second Exchange Agreement with Convertible Noteholder; Reducing Company Debt by more than $60 million

GlobeNewswire

a year ago

RYVYL Announces Second Exchange Agreement with Convertible Noteholder; Reducing Company Debt by more than $60 million

Sonim Technologies Third Quarter 2023 Earnings: EPS: US$0.013 (vs US$0.045 loss in 3Q 2022)

Simply Wall St.

a year ago

Sonim Technologies Third Quarter 2023 Earnings: EPS: US$0.013 (vs US$0.045 loss in 3Q 2022)

RenovoRx Expands Scientific Advisory Board with Appointment of Michel Ducreux, M.D., Ph.D.

Business Wire

a year ago

RenovoRx Expands Scientific Advisory Board with Appointment of Michel Ducreux, M.D., Ph.D.

Duos Technologies Group Reports Third Quarter 2023 Results

GlobeNewswire

a year ago

Duos Technologies Group Reports Third Quarter 2023 Results

RenovoRx Reports Third Quarter 2023 Financial Results and Operational Highlights

Business Wire

a year ago

RenovoRx Reports Third Quarter 2023 Financial Results and Operational Highlights

GuruFocus.com

a year ago

Beneficient (BENF) Reports Mixed Second Quarter Fiscal 2024 Results

Beneficient Reports Results for Second Quarter Fiscal 2024

GlobeNewswire

a year ago

Beneficient Reports Results for Second Quarter Fiscal 2024

Software Acquisition Group Inc. III (NASDAQ:SWAG) Q3 2023 Earnings Call Transcript

Insider Monkey

a year ago

Software Acquisition Group Inc. III (NASDAQ:SWAG) Q3 2023 Earnings Call Transcript

Associated Press Finance

a year ago

Psychemedics: Q3 Earnings Snapshot

Psychemedics Corporation Reports Third Quarter 2023 Financial Results

GlobeNewswire

a year ago

Psychemedics Corporation Reports Third Quarter 2023 Financial Results

OncoCyte Corp (OCX) Reports Q3 2023 Financial Results with Key Product Launches on the Horizon

GuruFocus.com

a year ago

OncoCyte Corp (OCX) Reports Q3 2023 Financial Results with Key Product Launches on the Horizon

Benson Hill Announces Third Quarter 2023 Financial Results, Improves 2023 Outlook, and Pays Down Debt

Business Wire

a year ago

Benson Hill Announces Third Quarter 2023 Financial Results, Improves 2023 Outlook, and Pays Down Debt

Nortech Systems Reports Third Quarter 2023 Results

Business Wire

a year ago

Nortech Systems Reports Third Quarter 2023 Results

Business Wire

a year ago

Permianville Royalty Trust Announces Second Special Cash Distribution of Net Proceeds from Permian Basin Divestiture

Ventyx Biosciences Announces Results from the Phase 2 Trial of VTX958 in Patients with Moderate to Severe Plaque Psoriasis and Provides Corporate Update

GlobeNewswire

a year ago

Ventyx Biosciences Announces Results from the Phase 2 Trial of VTX958 in Patients with Moderate to Severe Plaque Psoriasis and Provides Corporate Update

TSR, Inc.'s (NASDAQ:TSRI) Stock Is Going Strong: Is the Market Following Fundamentals?

Simply Wall St.

a year ago

TSR, Inc.'s (NASDAQ:TSRI) Stock Is Going Strong: Is the Market Following Fundamentals?

Share on Social Networks: